DENTSPLY SIRONA Inc. $XRAY Shares Bought by Brandes Investment Partners LP

Brandes Investment Partners LP boosted its holdings in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 83.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 856,878 shares of the medical instruments supplier’s stock after buying an additional 389,242 shares during the quarter. Brandes Investment Partners LP’s holdings in DENTSPLY SIRONA were worth $9,794,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in XRAY. AQR Capital Management LLC lifted its holdings in DENTSPLY SIRONA by 109.8% during the 2nd quarter. AQR Capital Management LLC now owns 13,316,771 shares of the medical instruments supplier’s stock worth $211,470,000 after buying an additional 6,970,086 shares in the last quarter. Armistice Capital LLC lifted its holdings in DENTSPLY SIRONA by 1,044.0% during the 3rd quarter. Armistice Capital LLC now owns 5,736,000 shares of the medical instruments supplier’s stock worth $72,790,000 after buying an additional 5,234,587 shares in the last quarter. Jacobs Levy Equity Management Inc. lifted its holdings in DENTSPLY SIRONA by 662.0% during the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 4,608,341 shares of the medical instruments supplier’s stock worth $58,480,000 after buying an additional 4,003,606 shares in the last quarter. Goldman Sachs Group Inc. lifted its holdings in DENTSPLY SIRONA by 827.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 2,434,925 shares of the medical instruments supplier’s stock worth $36,378,000 after buying an additional 2,172,343 shares in the last quarter. Finally, Brickwood Asset Management LLP increased its position in shares of DENTSPLY SIRONA by 5,515.8% in the 3rd quarter. Brickwood Asset Management LLP now owns 1,524,074 shares of the medical instruments supplier’s stock valued at $19,340,000 after purchasing an additional 1,496,935 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Trading Down 4.1%

Shares of DENTSPLY SIRONA stock opened at $10.04 on Thursday. DENTSPLY SIRONA Inc. has a 1 year low of $9.40 and a 1 year high of $17.09. The company has a debt-to-equity ratio of 1.52, a quick ratio of 0.98 and a current ratio of 1.53. The company has a market capitalization of $2.01 billion, a P/E ratio of -3.19, a PEG ratio of 1.25 and a beta of 0.89. The company’s fifty day moving average is $11.04 and its two-hundred day moving average is $11.72.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Tuesday, May 5th. The medical instruments supplier reported $0.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.28 by ($0.01). DENTSPLY SIRONA had a positive return on equity of 18.83% and a negative net margin of 17.06%.The business had revenue of $880.00 million for the quarter, compared to analysts’ expectations of $841.80 million. During the same period in the previous year, the business posted $0.43 earnings per share. The company’s revenue for the quarter was up .1% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. Analysts forecast that DENTSPLY SIRONA Inc. will post 1.42 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages have commented on XRAY. Zacks Research raised shares of DENTSPLY SIRONA from a “strong sell” rating to a “hold” rating in a research report on Monday, March 2nd. Robert W. Baird increased their price objective on shares of DENTSPLY SIRONA from $12.00 to $14.00 and gave the company a “neutral” rating in a research report on Friday, February 27th. Barclays dropped their price objective on shares of DENTSPLY SIRONA from $12.00 to $9.00 and set an “underweight” rating on the stock in a research report on Thursday, June 4th. UBS Group dropped their price objective on shares of DENTSPLY SIRONA from $18.00 to $17.00 and set a “buy” rating on the stock in a research report on Thursday, May 7th. Finally, Mizuho dropped their price objective on shares of DENTSPLY SIRONA from $16.00 to $14.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 6th. Three equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, DENTSPLY SIRONA presently has an average rating of “Hold” and a consensus price target of $13.55.

DENTSPLY SIRONA Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.